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ABSTRACT 
Interaction of pendimethalin (PM) herbicide with human serum albumin (HSA) was 
studied using fluorescence, circular dichroism (CD) and molecular modeling methods. 
The attenuation of the fluorescence intensity of HSA in the presence of PM revealed 
formation of the PM-HSA complex. Analysis of the fluorescence quenching data showed 
moderately strong binding affinity between PM and HSA. Both hydrophobic interactions 
and hydrogen bonds were suggested to stabilize the PM-HSA complex, based on 
thermodynamic data. Binding of PM to HSA induced perturbation in the 
microenvironment around the aromatic fluorophores as well as secondary and tertiary 
structural changes in the protein. Complex formation between PM and HSA led to an 
increase in its thermal stability. Both site marker displacement and molecular modeling 
results suggested site I, located in subdomain IIA, as the preferred binding site of PM on 
HSA. A comparative study on the interaction between PM and serum albumins of bovine 
(BSA), sheep (SSA), porcine (PSA), human (HSA) and rabbit (RbSA) was also made 
using fluorescence quenching titration and site marker displacement experiments. Similar 
magnitude of PM-induced fluorescence quenching was observed with BSA and HSA, 
compared to other albumins. The binding affinity of PM to these albumins was found to 
follow the order: SSA > HSA > BSA > RbSA > PSA. Warfarin (WFN) displacement 
results also suggested similar displacing action of PM on WFN-BSA and WFN-HSA 
complexes. All these results suggested close similarity between BSA and HSA in terms 
of PM binding characteristics. 
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ABSTRAK 
Interaksi pendimethalin (PM) racun herba dengan pengangkut utama dalam edaran 
manusia, albumin serum manusia (HSA) dikaji menggunakan pendarfluor, dichroism 
bulat (CD) dan kaedah pemodelan molekul. Pengecilan keamatan pendarfluor di HSA di 
hadapan PM mendedahkan pembentukan kompleks PM-HSA. Analisis data pendarfluor 
pelindapkejutan menunjukkan pertalian mengikat sederhana kuat antara PM dan HSA. 
Kedua-dua interaksi hidrofobik dan ikatan hidrogen telah dicadangkan untuk 
menstabilkan kompleks PM-HSA, berdasarkan data termodinamik. Mengikat PM ke 
HSA pengusikan disebabkan dalam mikro di sekitar fluorophores aromatik serta 
perubahan struktur menengah dan pengajian tinggi dalam protein. Complexation PM 
dengan HSA membawa kepada peningkatan dalam kestabilan haba. Kedua-dua penanda 
tapak anjakan dan keputusan pemodelan molekul mencadangkan laman web saya, 
bertempat di subdomain IIA sebagai tapak mengikat yang digemari PM di HSA. Satu 
kajian perbandingan pada interaksi antara PM dan albumins serum lembu (BSA), biri-biri 
(SSA), babi (PSA), manusia (HSA) dan arnab (RbSA) juga dibuat menggunakan 
pendarfluor pelindapkejutan titratan dan tapak eksperimen penanda anjakan. Magnitud 
yang sama pelindapkejutan pendarfluor PM yang disebabkan diperhatikan dengan BSA 
dan HSA, berbanding albumins lain. Pertalian mengikat PM untuk albumins ini didapati 
untuk mengikuti susunan: SSA> HSA> BSA> RbSA> PSA. Keputusan Warfarin (WFN) 
anjakan juga mencadangkan tindakan penyisihan sama PM pada WFN-BSA dan 
kompleks WFN-HSA. Semua keputusan mencadangkan persamaan rapat antara BSA dan 
HSA, dari segi ciri-ciri pengikatan PM.  
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CHAPTER 1 
INTRODUCTION 
Herbicides have been found useful in improving crop production in agricultural fields. 
However, their extensive use has provoked environmental and toxicological threats due 
to their persistency in the environment (Edwards and Adams, 1970). Pendimethalin (PM), 
a member of dinitroaniline group of herbicides is a soil residual pre-emergence herbicide, 
which is used primarily for the control of most annual grasses and certain broad-leaved 
weeds in various crops such as corn, wheat, soybeans and grapes. PM represses both root 
and shoot development via inhibition of chromosome separation and cell wall formation 
during cell mitosis (Appleby and Valverde, 1989; Gilliam et al., 1993). PM is a widely 
used herbicide in the world, particularly in the developed countries. 
Due to its vast usage, PM has been detected as a contaminant in the water sources in 
USA (Larson et al., 1999), Denmark (Asman et al., 2005), Spain (Barba-Brioso et al., 
2010) and France (CORPEP, 2010). The harmful chemicals of herbicides in the soil may 
leach into the water sources and cycle in the food web from aquatic organisms to human 
beings (Edwards and Adams, 1970). Several studies have reported the toxicological 
effects of PM on the aquatic organisms and other mammalian species (Danion et al., 2012; 
Dimitrov et al., 2006; Poleksic et al., 1995). Nevertheless, it is of much concern about the 
effects of PM on humans as the harmful compounds in the herbicides may reach humans 
directly through air after aerosol application or indirectly via food and drinking water.  
Interaction of exogeneous compounds with the plasma proteins in human circulation 
decides the fate of their availability, metabolism and distribution in the body. Thus, 
interaction studies with the transport proteins become important to decipher their action 
in the human body. Human serum albumin (HSA) is the major transporter of many 
exogeneous and endogeneous compounds in human circulation. It is a single polypeptide 
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chain of 585 amino acid residues with a sole tryptophan residue (Trp-214) and is 
comprised of three homologous domains, namely, I, II and III. Most of the compounds 
have been found to bind with high affinity to Sudlow’s sites I or II, which are located in 
subdomains IIA and IIIA, respectively (Carter et al., 1989; Sudlow et al., 1975). The 
toxicity of a herbicide depends on the level of its free concentration in the blood stream. 
Therefore, binding of a herbicide to HSA is toxicologically important as it can reduce the 
concentration of free herbicide. However, interaction of other endogeneous substances or 
drugs with HSA at the same binding site of the herbicide might strongly affect its 
distribution, elimination as well as its toxic properties (Bertucci and Domenici, 2002). 
Furthermore, unusually high affinity of the herbicide to HSA may influence its 
transportation and thus prevent its release at the target site for elimination purposes 
(Carter and Ho, 1994). Thus, a detailed study on the interaction between PM and HSA is 
required to understand its transport in human circulation. 
The toxicological effects of PM on the human system can be predicted from the animal 
model study, which may provide useful information on the compound toxicity (Cicchetti 
et al., 2009). This makes the selection of an animal model an important subject. In 
principle, this selection is based on the similarity of the toxicokinetics / toxicodynamics 
of PM, including its transport in the blood circulation, between animal and human systems 
(Davidson et al., 1987). Most of the exogenous compounds including toxins are being 
transported in the circulation through serum albumin, which carries them to different 
target organs for further metabolism (Peters, 1996). Therefore, it is imperative to study 
the similarity in the transport of any ligand in the blood circulation of human and animal 
systems (Poόr et al., 2014). In view of this, a comparative study on the binding 
characteristics of PM towards serum albumins of human (HSA),  bovine (BSA),  porcine 
(PSA),  sheep (SSA)  and  rabbit (RbSA) is essential. 
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Problem statement 
Does PM bind to HSA? If yes, what are the binding characteristics of PM-HSA interaction 
and which mammalian albumin shows close similarity to HSA in terms of PM binding 
characteristics? 
In order to answer the above questions, the following objectives were set: 
1. To study the interaction of PM with HSA in terms of binding affinity, binding forces 
and location of the binding site. 
2. To study the effect of ligand binding on the conformation and thermal stability of 
HSA. 
3. To compare PM binding characteristics in different mammalian serum albumins. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1  Herbicides 
Herbicides are chemicals used to kill or interrupt the normal growth of weeds, i.e. 
plants with more undesirable characteristics compared to its goodness (Hartwig, 1996). 
Herbicides were first introduced in 1940s and rapid development in the use of herbicides 
occurred after World War II (Zimdahl, 1993). The dominance of herbicides for weed 
control occurred during the revolution in the agriculture field, where herbicides save 
human energy and farmers achieved better crop quality and increased crop production at 
lower cost. According to one approximation, herbicides were used to reduce weed 
population on approximately 220 million acres of U.S. cropland (Gianessi and Reigner, 
2007).  
2.1.1 Classification of herbicides 
Herbicides can be classified on the basis of selectivity, time of application, chemical 
structure and mechanism of action (Zimdahl, 1993).  
On the selectivity ground, herbicides are grouped as ‘selective’ and ‘non-selective’ 
herbicides. ‘Selective’ herbicides are those that kill or suppress the targeted weeds 
without harming the desirable plant species, whereas ‘non-selective’ herbicides kill all 
plants when applied at right rate. Selectivity is not a precise system of classification as it 
is also affected by many other factors such as plant age and stage of growth, plant 
morphology, absorption, translocation, time and method of application, herbicide 
formulation and environmental conditions (Zimdahl, 1993). 
Time of herbicide application is referred to ‘pre-plant’, ‘pre-emergence’ and ‘post-
emergence’ applications. ‘Pre-plant’ applications are usually performed by introducing 
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the herbicides into the soil before planting. Application of herbicides after planting but 
prior to emergence of the crops or weeds is known as ‘pre-emergence’ application. If the 
herbicides are applied after the crop and/or weed have emerged, it is known as ‘post-
emergence’ application (Zimdahl, 1993). 
Based on the similarities in their chemical structures, herbicides of the same chemical 
group generally show common physiological characteristics. However, slight 
modification of a functional group may lead to significant change in the activity, 
selectivity, persistence and mode of action of a herbicide (Sherwani et al., 2015; Varshney 
and Sondhia, 2008).  
Mechanism of action is referred to the biochemical and biophysical responses of the 
plants upon herbicidal treatment (Zimdahl, 1993). Herbicides of the same chemical 
family usually have the same mechanism of action. On the other hand, it is also possible 
for the herbicides with different chemical structures to possess the same action 
mechanism. Table 2.1 shows examples of the chemical family of several herbicides and 
their mechanism of action. The detailed information about the classification of herbicides 
is available in the Herbicide Handbook of the Weed Science Society of America (Vencill, 
2002). 
2.2 Pendimethalin  
Pendimethalin (PM) [N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine], whose chemical 
structure is given in Figure 2.1, is a member of dinitroaniline group of herbicides and is 
registered in all European Union countries. It is commonly used in controlling most 
annual grasses and certain broadleaf weeds in various crops such as corn, potatoes, wheat, 
soybeans, cotton, tobacco, peanuts, grapes and onions (Tsiropoulos and Lolas, 2004). 
Approximately 9000 tons of PM were used for agricultural purposes in the USA in 1992 
where around 60 % of it was applied in soybean fields (USGS, 1998). PM was found to  
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Table 2.1: Classification of several herbicides based on chemical structure and 
mode of action. 
Mode of action Chemical family Common name 
Inhibition of acetyl CoA 
carboxylase 
Aryloxyphenoxy propionate 
 
Cyclohexanedione 
- Dichlofop 
- Haloxyfop 
- Alloxydim 
- Butroxydim 
 
 
Inhibition of acetolactate 
synthase 
Imidazolinone 
 
Pyrimidinylthio-benzoate 
 
Sulfonylurea 
 
Triazolopyrimidine 
- Imazamethabenz 
- Imazaqum 
- Bispyribac-sodium 
- Pyrithiobac 
- Ethoxysulfuron 
- Iodosulfuron 
- Cloransulam-methyl 
- Diclosulam 
Inhibition of microtubule 
assembly 
Dinitroaniline 
 
Pyridine 
- Pendimethalin 
- Trifuralin 
- Dithiopyr 
- Thiazopyr 
 
Synthetic auxins 
Phenoxy 
 
Benzoic acid 
Carboxylic acid 
- 2,4-D 
- Dichlorprop, 2,4-DP 
- Dicamba 
- Clopyralid 
- Picloram 
 
Inhibition of photosynthesis 
at photosystem II site A 
Pyridazinone 
Triazine 
 
Uracil 
- Pyrazon 
- Atrazine 
- Prometryn 
- Bromacil 
Inhibition of photosynthesis 
at photosystem II site B 
Benzothiadiazole 
Nitrile 
- Bentazon 
- Bromoxynil 
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Table 2.1: continued 
Inhibition of lipid synthesis;  
not ACCase inhibition 
Thiocarbamate 
- Prosulfocarb 
- Vernolate 
Inhibition of carotenoid 
biosynthesis 
Triazole 
- Amitrole 
- Aclonifen 
Inhibition of the phytoene 
desaturase 
Pyridazinone 
Pyridinecarboxamide 
- Norflurazon 
- Picolinafen 
Photosystem I electron 
diverters 
Bipyridylium 
- Diquat 
- Paraquat 
Inhibition of synthesis of very 
long-chain fatty acids 
Acetamide 
Chloroacetamide 
- Napropamide 
- Acetochlor 
- Metalochlor 
Inhibitiom of mitosis Carbanilate - Carbetamide 
Membrane disruption Dinitrophenol - Dinoterb 
Taken from Mallory-Smith and Retzinger (2003) 
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Figure 2.1:  Chemical structure (A) and ball-and-stick model (B) of pendimethalin. 
 
  
A 
B 
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be one of the most effective pre-emergence herbicides used in dry-seeded rice among the 
available herbicides in Bangladesh (Ahmed and Chauhan, 2014). Being classified as a 
selective herbicide, it kills the targeted weeds by inhibiting microtubule synthesis, which 
are needed in cell wall formation and chromosomal separation during cell mitosis (Parka 
and Soper, 1977). PM (trade name: Prowl) is available in the market in the form of 
emulsifiable concentrate, wettable powder or dispersible granule formulations.  
2.2.1 The fate of PM in soil 
The rate of degradation of PM in soil depends on the method of application as well as 
the soil properties such as soil type, soil temperature and soil moisture content. PM is 
found to be more persistent when it is applied by incorporation than its application on the 
soil surface. The half-life of PM varies from 72 to 172 days at 25 °C and depends on soil 
types, thus reflecting its different persistency levels in the soil. At the same temperature, 
the half-life increases with decreasing soil moisture content, whereas it shows slower rate 
of degradation at lower temperatures (Walker and Bond, 1977). A certain persistence 
level of herbicides in soil might be useful for efficient control of weeds (Tsiropoulos and 
Lolas, 2004).  
PM has low water solubility  (0.3 mg L−1 at 20°C),  moderate to  high  vapor  pressure  
(4.0 mPa at 25 °C) and strong adsorption to soil (Koc = 7 011 ml g
−1 in loamy sandy soil 
of 0.87 % organic carbon) (Tomlin 1997). Therefore, movement of this herbicide in 
surface runoff and leaching under normal usage is expected to be low except through 
sediment transport of adsorbed herbicide during soil erosion (Starett et al., 1996; Suzuki, 
2000).  
2.2.2 Environmental impact of PM  
The extensive use of PM in agriculture may lead to environmental contamination. 
Figure  2.2  shows  the  possible  routes  through  which  herbicides can  reach  different 
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Figure 2.2: Schematic diagram showing the cycling of pesticides in the environment. 
  (Acquired from Edwards and Adams, 1970)  
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environments and its cycle in the environment. The soil may serve as a reservoir of PM 
residues due to its strong adsorption to the soil. However, these PM residues may reach 
other parts of the environment, i.e. the aquatic environment and the air through 
agricultural runoff, leaching, drift, evaporation and aerosol application and thus causes 
water and air pollutions (Edwards and Adams, 1970; Strandberg and Scott-fordsmand, 
2004). As an evidence to it, presence of PM was detected in the pond water and sediment 
originating from runoff from a commercial nursery in South Carolina (Riley et al., 1994) 
as well as in streams draining soils in agricultural areas at concentration up to 0.1 µg/L in 
Denmark (Lokke, 1999). PM was also detected as a contaminant in surface water, air and 
precipitation in USA in the years 1998 and 1999 (Capel et al., 1998; Larson et al., 1999). 
PM has been reported as one of the most frequently detected contaminants of groundwater 
in Portugal, which exceeded the EU regulatory limit (Goncalves et al. 2007). A recent 
study has reported that White Nile River, recycle and drainage water in Kenana, Sudan 
were contaminated by PM due to its heavy use for weed control in White Nile State (Abd-
Algadir et al., 2011). 
2.2.3 Adverse effects of PM to the biota 
Soil and sediment provide habitat for wide variety of soil biota. Sediment 
contamination directly affects the ecology of these sediment-inhabiting organisms. A 
study on the effect of PM on the soil populations reported significant decrease in the 
number of bacteria, fungi and actinomycetes upon exposure to PM (Nayak et al., 1994). 
PM was found to inhibit the formation of sporangia and reduce the motility of zoospore 
of certain population of fungi (Wilcox, 1996). Besides, PM was also found to cause 
genotoxic effect on maize and onion by inducing chromosomal aberration in the root 
meristematic cells of the exposed plants (Promkaew et al., 2010).  
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The US Environmental Protection Agency (EPA) has classified PM as a persistent 
bioaccumulative toxic (PBT) agent and a possible ‘Group C’ human carcinogen (Megadi 
et al., 2010). The adverse effects of PM on the fresh-water population including 
phytoplankton, zooplankton and bottom fauna have also been reported (Poleksic et al., 
1995). A study on Nile tilapia (Oreochromis niloticus), a common freshwater fish has 
shown significant decrease in body weight and increased levels of serum glucose, alkaline 
phosphatase, aspartate amino transferase, total protein and cholesterol in the fish upon 
exposure to PM. In addition, PM was also found to induce genotoxic effects on the PM-
exposed fish (El-Sharkawy et al., 2011). Danion et al. (2014) have also shown 
deactivation of ethoxyresorufin-O-deethylase in the liver of PM-treated fish. Numerous 
in vitro studies conducted on the other terrestrial animals have shown induction of 
chromosomal aberration and formation of micronuclei in bone marrow cells of PM-
treated mice (Dimitrov et al., 2006) as well as DNA strand breaks in Chinese hamster 
ovary cells upon exposure to PM (Patel et al., 2007). 
2.2.4 The fate of PM in the mammalian system 
An in vivo study using rat as a model (Zulalian, 1990) showed that rats treated with a 
single oral dose (37 mg kg–1 body weight) of [14C]-4-methyl-labeled PM excreted major 
portion of the dose within 24 h both in urine and feces. However, less than 0.3 ppm PM 
residues were found in all tissues after 96 h except the fat which retained 0.9 ppm residues 
due to the lipophilic natue of PM or its metabolites. In view of the effectiveness of liver 
and kidney to remove PM and its metabolites from the blood, highest level of PM residues 
were detected at 6 h in these tissues. The major metabolic reactions of PM include 
hydroxylation of the 4-methyl and the N-1-ethyl group, oxidation of these alkyl groups 
to carboxylic acids, nitro reduction, cyclization and conjugation. Whereas the oxidation 
products were predominant in urine, methylbenzimidazolecarboxylic acids (products of 
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cyclization reactions) were found as unique metabolites in liver and kidney (Zulalian, 
1990).  
2.2.5 The importance of the interaction between PM and serum albumin 
The toxicity of a compound is closely related to its toxicokinetics (change in 
concentration of a toxicant over time during absorption, distribution, biotransformation 
and elimination process) and toxicodynamics (interaction of a toxicant with biological 
target and its molecular, biochemical and physiological effects) in biological systems 
(Ringot et al., 2006). In order to exert its toxic effect, a toxicant should exist in its free 
state. Therefore, binding of the potential toxic compounds to the transport proteins in 
blood circulation is extremely important as it may reduce the bioavailability of the free 
toxicant. As evident from a previous study (Lie and Bratlid, 1970), binding of bilirubin 
to serum albumin led to its detoxification. Thus, transport proteins play crucial roles to 
carry toxic compounds especially those with low water solubility to the target site for 
elimination purposes (Vallner, 1977). Since PM exhibits low solubility in water, it is 
important to understand its interaction with the main transport protein in the human blood 
circulation, i.e. human serum albumin.  
2.3 Human serum albumin  
 Human serum albumin (HSA) is coded by a single gene situated on the long arm of 
chromosome 4, near the centromere at position q11-22 (Harper and Dugaiczyk, 1983). 
The basic pathway of albumin synthesis follows the route: ribosome → rough 
endoplasmic reticulum → Golgi apparatus → exocytosis (Glaumann, 1970; Peters et al., 
1971). It is synthesized in liver with the cleavage of the N-terminal peptide of the nascent 
chain before its release from the rough endoplasmic reticulum. The product, proalbumin 
is again cleaved at its N-terminal (Arg-Cly-Val-Phe-Arg-Arg) in the Golgi apparatus to 
produce secreted albumin (Peters and Davidson, 1982). 
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 HSA is the predominant protein in the blood plasma at a concentration of about 40 mg 
mL–1 (Evans, 2002). However, this only constitutes 40 % of the total albumin content, the 
remaining albumin is distributed in the extracellular locations such as skin, muscle, fluids 
of the body (cerebrospinal, pleural, peritoneal, pericardial, amniotic fluids etc.) as well as 
secretions including milk, sweat, tears and saliva (Peters, 1996). 
2.3.1 Physicochemical properties of HSA 
 The major physicochemical properties of HSA are shown in Table 2.2. It has a 
molecular mass of 66 kDa as obtained from the calculation based on its amino acid 
composition (66 438 Da) as well as matrix-assisted laser desorption/ionization-time of 
flight (MALDI-TOF) mass spectrometry (66 479 Da) (Dockal et al., 1999; Minghetti et 
al., 1986). Oncley et al. (1947) have reported the values of the diffusion coefficient 
(D20,W),  the sedimentation coefficient (S20,W)  and the frictional ratio  of   HSA  as 6.1 × 
10–7 cm2 s–1,  4.5 S and 1.28:1, respectively. Based on the frequency dispersion of the 
dielectric constant study, the axial ratio of HSA has been predicted as 3:1 (Scheider et al., 
1976). The radius of gyration has been found to be 26.7 Å (Carter and Ho, 1994). The 
shape of HSA is described as a 3-D equilateral triangle with sides of 80 Å and a depth of 
30 Å (He and Carter, 1992). HSA has the intrinsic viscosity, [η] and partial specific 
volume, ?̅?2 as 0.046 dL g
–1 and 0.733 cm3 g–1, respectively (Hunter, 1996). Its isoelectric 
point varies from 4.7 (in the native form) to 5.8 (in the fatty acid free form) (Longsworth 
and Jacobsen, 1949). The isoionic point of HSA has been reported as 5.16 (Hughes, 1954), 
whereas the calculated net charge at pH 7.4 is –19 (Tanford, 1950). HSA exhibits a 
specific absorption coefficient, ɛ1 𝑐𝑚
1 %  of 5.3 at 280 nm (Wallevik, 1973). HSA mainly 
consists of α-helical structure (67 %), whereas the rest of the residues are folded in β-
form (10 %) and flexible regions (23%) between subdomains (Carter and Ho, 1994).  
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Table 2.2: Physicochemical properties of HSA. 
Property Value Reference 
Molecular mass 
   - Amino acid composition 
   - MALDI-TOF 
 
66 438 Da 
66 479 Da 
 
Minghetti et al. (1986) 
Dockal et al. (1999) 
Diffusion coefficient, D20,W 6.1 × 10
–7 cm2 s–1 Oncley et al. (1947) 
Sedimentation coefficient, S20,W 4.5 S Oncley et al. (1947) 
Frictional ratio 1.28:1 Oncley et al. (1947) 
Axial ratio 3:1 Scheider et al. (1976) 
Radius of gyration 26.7 Å Carter and Ho (1994) 
Overall dimension 80 × 80 × 30 Å He and Carter (1992) 
Intrinsic viscosity, [η] 0.046 dL g–1 Hunter (1996) 
Partial specific volume, ?̅?2 0.733 cm
3 g–1 Hunter (1996) 
Isoelectric point 
   - Native 
  
  - Defatted 
 
4.7 
 
5.8 
 
Longsworth and Jacobsen 
(1949) 
Gianazza et al. (1984) 
Isoionic point 5.16 Hughes (1954) 
Net charge (pH 7.4) –19 Tanford (1950) 
ɛ1 𝑐𝑚
1 %  at 280 nm 5.3 Wallevik (1973) 
Secondary structures 
   - α-helix  
 
67 % 
 
Carter and Ho (1994) 
   - β-form  10 % Carter and Ho (1994) 
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2.3.2 Structural organization of HSA 
 The primary structure of HSA, i.e. its amino acid sequence and disulfide bonding 
pattern is shown in Figure 2.3. HSA consists of 585 amino acid residues, which form nine 
loops and are linked together by 17 disulfide bridges. These are further grouped into three 
homologous domains, consisting triplets of long-short-long loops. The different domains 
of HSA are named as domain I (residues 1-195), domain II (residues 196-383) and domain 
III (residues 384-585), as indicated by arrows in Figure 2.3. These domains are further 
divided into several subdomains. The first two loops of each domain, viz. loops 1-2, 4-5 
and 7-8 are grouped into subdomains IA, IIA and IIIA, respectively; whereas loops 3, 6 
and 9 form subdomains IB, IIB and IIIB, respectively (Peters, 1996). As illustrated in 
Figure 2.4, subdomains A consist of six α-helices, whereas subdomains B are made up of 
four α-helices. The helices, h1-h4 share the similar pattern between subdomains A and B. 
However, there are extra two short helices (h5 and h6) in subdomains A. A total of 35 
cysteine residues are present in HSA, where 34 of them form 17 disulfide bridges that 
connect these helices (Sugio et al., 1999). The arrangement of different subdomains of 
HSA in its three-dimensional structure is shown in Figure 2.5. 
2.3.3 Functions of HSA 
 One of the major functions of HSA is to act as a transport protein in the blood 
circulation for the distribution of a wide variety of compounds such as steroid hormones, 
vitamin D, bile salts, fatty acids, amino acids, etc., which possess low water solubility. It 
also carries metal ions, i.e. zinc, iron, calcium, copper and chloride in the blood stream 
(Peters, 1996). HSA has also been reported to transport various exogeneous ligands such 
as pharmaceutical drugs (Kragh-Hansen et al., 2002; Otagiri, 2005; Peters, 1996) and 
potential toxic compounds (Tunç et al., 2014; Zhang et al., 2013). Besides, it also 
transports toxic metabolites (e.g. bilirubin) to the liver for detoxification (Knudsen et al.,  
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Figure 2.3:  Amino acid sequence and disulfide bonding pattern of human serum 
albumin. A triple-domain structure of internal homology is indicated by 
arrows. (Acquired from Dugaiczyk et al., 1982)  
Loop 1 
Loop 2 
Loop 3 
Loop 4 
Loop 5 
Loop 6 
Loop 7 
Loop 8 
Loop 9 
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Figure 2.4: Schematic diagram showing the helices and disulfide bridges of HSA. 
Helices are shown in rectangles; loops and turns are indicated by thin 
lines; disulfide bridges are drawn with thick lines. The sequence 
nomenclature was derived from Minghetti et al., 1986. (Acquired from 
Sugio et al., 1999)  
19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5:   Three-dimensional structure of HSA, showing six subdomains in different 
colors. (Adapted from RCSB Protein Data Bank, PDB ID code 1BM0). 
  
IA 
IB 
IIA 
IIIB 
IIIA 
IIB 
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1986). In addition, HSA also acts as a depot protein for nitric oxide, a major signaling 
molecule (Stamler et al., 1992).  
 HSA plays important role in the regulation of colloid osmotic pressure (Quinlan et al., 
2005) and the maintenance of blood pH (Figge et al., 1991). It also functions as an anti-
oxidant by binding free copper (Cu2+) ions, which are responsible for the production of 
reactive oxygen and nitrogen species (Evans, 2002). Besides, HSA is known to possess 
esterase activity (Dubois-Presle et al., 1995). 
2.3.4 Ligand binding sites of HSA 
 HSA has been reported to bind large number of ligands at different ligand binding sites 
(Curry et al., 1998; Peters, 1996). Majority of the ligands bind reversibly to HSA with an 
association constant, falling in the range of 104 to 106 M–1 (Carter and Ho, 1994; Kragh-
Hansen et al., 2002). Sudlow et al. (1975) identified two specific ligand binding sites on 
HSA, namely, site I and site II, based on fluorescent probe displacement study. Sites I 
and II were found to be located in domains II and III, respectively, on the basis of peptic 
and tryptic digestion results (Bos et al., 1988). Later on, crystallographic studies assigned 
the locations of sites I and II in subdomains IIA and IIIA, respectively (Carter and Ho, 
1994; Curry et al., 1998; Sugio et al., 1999). Several ligands and their respective binding 
sites are shown in Figure 2.6. Names of the ligands, which share the same binding sites 
have also been included in the figure. 
2.3.4.1 Site I 
 Site I is made up of a pair of nonpolar clusters with two centrally-located clusters of 
polar residues, formed by Lys-195, Lys-199, Arg-218 and Arg-222 at the entrance, and 
Tyr-150, His-242 and Arg-257 at the bottom of the pocket (Ghuman et al., 2005). Site I 
seems to be a large and flexible binding region as it can fit wide variety of ligands 
including those with large molecular structure (e.g. bilirubin). Ligands that bind to site I  
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Figure 2.6: Three-dimensional structure of HSA showing various ligand binding 
sites. Ligands are depicted in space-filling models; oxygen atoms are 
colored red; all other atoms in fatty acids, other endogeneous ligands 
(hemin and thyroxine) and drugs are colored black, grey and orange, 
respectively. (Acquired from Ghuman et al., 2005) 
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with high affinity are usually bulky heterocyclic compounds with a negative charge or 
dicarboxylic acids (Kragh-Hansen et al., 2002). Several studies have shown the 
complexity of site I. Fehske et al., (1982) reported mutual interactions between warfarin 
and azapropazone at site I due to overlapping binding regions, whereas Kragh-Hansen 
(1985 and 1988) suggested presence of two independent binding regions within site I. On 
the other hand, Yamasaki et al. (1996) proposed the existence of three binding regions 
within this site, i.e. subsites Ia, Ib and Ic, which are the binding regions for warfarin, 
azapropazone and butamben, respectively. The location of the single Trp residue (Trp-
214) of HSA is in the non-overlapping region of warfarin site (Fehske et al., 1982). 
2.3.4.2 Site II 
 The pocket of site II is lined by hydrophobic side chains and the double disulfide 
bridges of helix IIIa-h3. The side chain of Arg- 410 is located at the entrance of the pocket, 
whereas the hydroxyl of Tyr-411 faces toward the inside of the pocket (Sugio et al., 1999). 
According to Kragh-Hansen et al., (2002), aromatic carboxylic acids with a negatively 
charged group at one end of the molecule away from the hydrophobic center tend to bind 
to site II on HSA. Site II appears to be smaller and narrower compared to site I, as large 
molecules are rarely found to bind to this site. In addition, no overlapping subsites are 
seen in site II. It is also less flexible because ligand binding is often strongly influenced 
by stereoselectivity (Kragh-Hansen et al., 2002). This was supported by the evidence that 
the binding affinity of L-Trp to site II was 100 times higher than its D-isomer (Kragh-
Hansen et al., 2002). Furthermore, substitution of site II ligands with a small group may 
influence its binding as evident from the inhibition of binding of fluorinated diazepam to 
this site, which is known as the preferred binding site of diazepam (Chuang and Otagiri, 
2001).  
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2.4 Serum albumins of different mammalian species 
 The amino acid compositions of five mammalian serum albumins, i.e. HSA, BSA, 
SSA, PSA and RbSA are shown in Table 2.3. The total number of amino acid residues of 
HSA and RbSA are 585 and 584, respectively, whereas BSA, SSA and PSA possess 
similar number (583) of amino acid residues. Albumins are rich in cysteine and charged 
amino acids but have low content of tryptophan, glycine and methionine (Brown and 
Shockley, 1982; Peters, 1985). The high percentage of total charged residues in albumin 
contributes to its solubility and the 17 disulfide bridges give its stability. All of these 
albumins have a Trp residue, invariably located in the long loop 4, whereas BSA, PSA 
and SSA possess an additional Trp residue in a homologous site in long loop 3 (Peters, 
1996).  
 The complete amino acid sequences of different mammalian serum albumins are 
shown in Figure 2.7. The sequence homology among these albumins is indicated in blue 
color (Figure 2.7) and is expressed as the protein sequence similarity score in Table 2.4. 
All these albumins show high degree of similarity (72-92 %) among each other. Similarity 
in the molecular weight is also noticed among these albumins, which varies from 66 015 
Da (rabbit) to 66 798 Da (porcine) (Michaud et al., 2009). 
 The use of animal models in modern biomedical research increased dramatically in the 
early 20th century (Ericsson et al., 2013). In order to select a suitable animal model, a few 
criteria such as close phylogenetic relationship or anatomical similarity between the 
animal and human as well as similar biochemical or physiological response to the process 
under investigation should be considered (Simon and Maibach, 2000). By using an animal 
model, the toxicological effect of PM can be extrapolated from animals to human. 
However, the validity of the extrapolation depends strictly on the interspecies similarities 
in ligand metabolism, physiology, absorption and distribution (Martinez, 2011). In order 
to identify the suitable animal model for further investigation in toxicological studies of  
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Table 2.3: Amino acid compositions of different mammalian albumins. 
Amino acid 
No. of residues 
Humana Bovinea Sheepb Porcinec Rabbitd 
Alanine 62 46 50 50 54 
Arginine 24 23 22 26 22 
Asparagine 17 14 14 13 12 
Aspartic acid 36 40 44 37 43 
Cysteine 35 35 35 35 35 
Glutamic acid 62 59 56 61 56 
Glutamine 20 20 19 20 14 
Glycine 12 16 17 16 20 
Histidine 16 17 18 18 23 
Isoleucine 8 14 13 23 16 
Leucine 61 61 61 62 62 
Lysine 59 59 60 57 57 
Methionine 6 4 4 - 1 
Phenylalanine 31 27 28 29 24 
Proline 24 28 28 30 29 
Serine 24 28 25 23 26 
Threonine 28 34 31 26 27 
Tryptophan 1 2 2 2 1 
Tyrosine 18 20 20 22 24 
Valine 41 36 36 33 38 
Total 585 583 583 583 584 
a Peters (1995); b Brown et al. (1989); c Weinstock and Badwin (1988); d NCBI PDB 
accession no. NP_001075813  
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 260 270 280 290 300 
Human LECADDRADL AKYICENQDS ISSKLKECCE KPLLEKSHCI AEVENDEMPA 
Bovine LECADDRADL AKYICDNQDT ISSKLKECCD KPLLEKSHCI AEVEKDAIPE 
Sheep  LECADDRADL AKYICDHQDA LSSKLKECCD KPVLEKSHCI AEVDKDAVPE 
Porcine LECADDRADL AKYICENQDT ISTKLKECCD KPLLEKSHCI AEAKRDELPA 
Rabbit LECADDRADL AKYMCEHQET ISSHLKECCD KPILEKAHCI YGLHNDETPA 
 
Contd….. 
 
 
 
 1                     10 20 30 40 50 
Human DAHKSEVAHR FKDLGEENFK ALVLIAFAQY LQQCPFEDHV KLVNEVTEFA 
Bovine DTHKSEIAHR FKDLGEEHFK GLVLIAFSQY LQQCPFDEHV KLVNELTEFA 
Sheep  DTHKSEIAHR FNDLGEENFQ GLVLIAFSQY LQQCPFDEHV KLVKELTEFA 
Porcine DTYKSEIAHR FKDLGEQYFK GLVLIAFSQH LQQCPYEEHV KLVREVTEFA 
Rabbit EAHKSEIAHR FNDVGEEHFI GLVLITFSQY LQKCPYEEHA KLVKEVTDLA 
      
      
 60 70 80 90 100 
Human KTCVADESAE NCDKSLHTLF GDKLCTVATL RETYGEMADC CAKQEPERNE 
Bovine KTCVADESHA GCEKSLHTLF GDELCKVASL RETYGDMADC CEKQEPERNE 
Sheep  KTCVADESHA GCDKSLHTLF GDELCKVATL RETYGDMADC CEKQEPERNE 
Porcine KTCVADESAE NCDKSIHTLF GDKLCAIPSL REHYGDLADC CEKEEPERNE 
Rabbit KACVADESAA NCDKSLHDIF GDKICALPSL RDTYGDVADC CEKKEPERNE 
      
      
 110 120 130 140 150 
Human CFLQHKDDNP NLPRLVRPEV DVMCTAFHDN EETFLKKYLY EIARRHPYFY 
Bovine CFLSHKDDSP DLPKL-KPDP NTLCDEFKAD EKKFWGKYLY EIARRHPYFY 
Sheep  CFLNHKDDSP DLPKL-KPEP DTLCAEFKAD EKKFWGKYLY EVARRHPYFY 
Porcine CFLQHKNDNP DIPKL-KPDP VALCADFQED EQKFWGKYLY EIARRHPYFY 
Rabbit CFLHHKDDKP DLPPFARPEA DVLCKAFHDD EKAFFGHYLY EVARRHPYFY 
      
      
 160 170 180 190 200 
Human APELLFFAKR YKAAFTECCQ AADKAACLLP KLDELRDEGK ASSAKQRLKC 
Bovine APELLYYANK YNGVFQECCQ AEDKGACLLP KIETMREKVL ASSARQRLRC 
Sheep  APELLYYANK YNGVFQECCQ AEDKGACLLP KIDAMREKVL ASSARQRLRC 
Porcine APELLYYAII YKDVFSECCQ AADKAACLLP KIEHLREKVL TSAAKQRLKC 
Rabbit APELLYYAQK YKAILTECCE AADKGACLTP KLDALEGKSL ISAAQERLRC 
      
      
 210 220 230 240 250 
Human ASLQKFGERA FKAWAVARLS QRFPKAEFAE VSKLVTDLTK VHTECCHGDL 
Bovine ASIQKFGERA LKAWSVARLS QKFPKAEFVE VTKLVTDLTK VHKECCHGDL 
Sheep  ASIQKFGERA LKAWSVARLS QKFPKADFTD VTKIVTDLTK VHKECCHGDL 
Porcine ASIQKFGERA FKAWSLARLS QRFPKADFTE ISKIVTDLAK VHKECCHGDL 
Rabbit ASIQKFGDRA YKAWALVRLS QRFPKADFTD ISKIVTDLTK VHKECCHGDL 
26 
 
 
 310 320 330 340 350 
Human DLPSLAADFV ESKDVCKNYA EAKDVFLGMF LYEYARRHPD YSVVLLLRLA 
Bovine NLPPLTADFA EDKDVCKNYQ EAKDAFLGSF LYEYSRRHPE YAVSVLLRLA 
Sheep  NLPPLTADFA EDKEVCKNYQ EAKDVFLGSF LYEYSRRHPE YAVSVLLRLA 
Porcine DLNPLEHDFV EDKEVCKNYK EAKDVFLGTF LYEYSRRHPD YSVSLLLRIA 
Rabbit GLPAVAEEFV EDKDVCKNYE EAKDLFLGKF LYEYSRRHPD YSVVLLLRLG 
      
      
 360 370 380 390 400 
Human KTYETTLEKC CAAADPHECY AKVFDEFKPL VEEPQNLIKQ NCELFKQLGE 
Bovine KEYEATLEEC CAKDDPHACY STVFDKLKHL VDEPQNLIKQ NCDQFEKLGE 
Sheep  KEYEATLEDC CAKEDPHACY ATVFDKLKHL VDEPQNLIKK NCELFEKHGE 
Porcine KIYEATLEDC CAKEDPPACY ATVFDKFQPL VDEPKNLIKQ NCELFEKLGE 
Rabbit KAYEATLKKC CATDDPHACY AKVLDEFQPL VDEPKNLVKQ NCELYEQLGD 
      
      
 410 420 430 440 450 
Human YKFQNALLVR YTKKVPQVST PTLVEVSRNL GKVGSKCCKH PEAKRMPCAE 
Bovine YGFQNALIVR YTRKVPQVST PTLVEVSRSL GKVGTRCCTK PESERMPCTE 
Sheep  YGFQNALIVR YTRKAPQVST PTLVEISRSL GKVGTKCCAK PESERMPCTE 
Porcine YGFQNALIVR YTKKVPQVST PTLVEVARKL GLVGSRCCKR PEEERLSCAE 
Rabbit YNFQNALLVR YTKKVPQVST PTLVEISRSL GKVGSKCCKH PEAERLPCVE 
      
      
 460 470 480 490 500 
Human DYLSVVLNQL CVLHEKTPVS DRVTKCCTES LVNRRPCFSA LEVDETYVPK 
Bovine DYLSLILNRL CVLHEKTPVS EKVTKCCTES LVNRRPCFSA LTPDETYVPK 
Sheep  DYLSLILNRL CVLHEKTPVS EKVTKCCTES LVNRRPCFSD LTLDETYVPK 
Porcine DYLSLVLNRL CVLHEKTPVS EKVTKCCTES LVNRRPCFSA LTPDETYKPK 
Rabbit DYLSVVLNRL CVLHEKTPVS EKVTKCCSES LVDRRPCFSA LGPDETYVPK 
 
 510 520 530 540 550 
Human EFNAETFTFH ADICTLSEKE RQIKKQTALV ELVKHKPKAT KEQLKAVMDD 
Bovine AFDEKLFTFH ADICTLPDTE KQIKKQTALV ELLKHKPKAT EEQLKTVMEN 
Sheep PFDEKFFTFH ADICTLPDTE KQIKKQTALV ELLKHKPKAT DEQLKTVMEN 
Porcine EFVEGTFTFH ADLCTLPEDE KQIKKQTALV ELLKHKPHAT EEQLRTVLGN 
Rabbit EFNAETFTFH ADICTLPETE RKIKKQTALV ELVKHKPHAT NDQLKTVVGE 
      
      
 560 570 580          585  
Human FAAFVEKCCK ADDKETCFAE EGKKLVAASQ AALGL  
Bovine FVAFVDKCCA ADDKEACFAV EGPKLVVSTQ TALA  
Sheep FVAFVDKCCA ADDKEGCFVL EGPKLVASTQ AALA  
Porcine FAAFVQKCCA APDHEACFAV EGPKFVIEIR GILA  
Rabbit FTALLDKCCS AEDKEACFAV EGPKLVESSK ATLG  
 
Figure 2.7:  Amino acid sequences of different mammalian albumins. Human 
(Minghetti et al., 1986); Bovine (Holowachuk, 1991); Sheep (Brown et al., 1989); Porcine 
(Weinstock and Baldwin, 1988); Rabbit (NCBI PDB accession no. NP_001075813) 
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Table 2.4: Molecular weight and sequence similarity score of different mammalian 
serum albumins. 
* Huang and Miller (1991) 
Adapted from: Michaud, F.T., Garnier, A., Lemieux, L., and Duchesne, C. Multivariate 
analysis of single quadrupole LC‐MS spectra for routine characterization and 
quantification of intact proteins. Proteomics. 2009. 9(3), 512-520. Copyright Wiley-VCI. 
(Reproduced with permission) 
 
  
Organism MW 
(Da) 
Protein sequence similarity score* 
Human Bovine Porcine Rabbit Sheep 
Human 66 472 1 0.77 0.77 0.75 0.76 
Bovine 66 433  1 0.80 0.72 0.92 
Porcine 66 798   1 0.75 0.78 
Rabbit 66 015    1 0.73 
Sheep 66 328     1 
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PM, a comparative study on the binding characteristics of PM towards serum albumins 
of different mammalian species is necessary. On the other hand, differences in serum 
composition (e.g. α1-glycoprotein level, amount of total body water and extracellular 
body water) has been reported to result in species-specific differences in ligand binding 
and transportation of ligand across the blood circulation. Furthermore, presence of 
competitors for the ligand binding site has also contributed to the differences in ligand-
protein interactions (Martinez, 2011). In spite of the close similarities among the five 
mammalian serum albumins used in this study, many other species-specific factors that 
may influence the in vivo performance should be taken into consideration. 
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CHAPTER 3 
MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Proteins 
Human serum albumin (HSA), essentially fatty acid free,  96 % (Lot # 068K7538V) 
was purchased from Sigma-Aldrich Co., USA. Other mammalian serum albumins, viz. 
bovine serum albumin (BSA),  96 % (Lot # 011M7406V), porcine serum albumin (PSA), 
 98 % (Lot # 084K7636), rabbit serum albumin (RbSA), ~ 99 %  (Lot # 104K7560) and 
sheep serum albumin (SSA),  97 % (Lot # 117K7540) were also the products of Sigma-
Aldrich Co., USA.  
3.1.2 Herbicide 
Pendimethalin (PM), Pestanal®, analytical standard (empirical formula: C13H19N3O4, 
molecular weight: 281.31) (Lot # SZBD302XV) was procured from Sigma-Aldrich Co., 
USA.  
3.1.3 Ligands used in site marker displacement studies 
Warfarin (WFN) (Lot # 104K1261), indomethacin (IDM) (Lot # 115K0689) and 
ibuprofen (IBN) (Lot # 122K0676V) were obtained from Sigma-Aldrich Co., USA.  
3.1.4 Miscellaneous 
Analytical grade quality of sodium dihydrogen phosphate and disodium hydrogen 
phosphate were purchased from SYSTERM®, Malaysia, whereas absolute ethanol was 
supplied by BDH Prolabo®, UK. Standard buffers of pH 7.0 and pH 10.0 were procured 
from Sigma-Aldrich Co., USA. Merck Millipore, Germany was the source of the PVDF 
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(0.45 µm) membrane filters, whereas cellulose nitrate (0.45 µm) membrane filters were 
supplied by Whatman®, England.  
Ultrapure (Type 1) water produced by Mili-Q water purification system (Merck 
Milipore, Germany) was used throughout this study. 
3.2 Methods 
3.2.1 pH measurements 
Delta 320 pH meter (Mettler-Toledo GmbH, Switzerland), attached with a HA405-
K2/120 combination electrode was used in pH measurements. Calibration of the pH meter 
was made with standard buffers of pH 7.0 and pH 10.0 before pH measurements in the 
neutral and alkaline pH ranges, respectively. The least count of the pH meter was 0.01 
pH unit. 
3.2.2 Sample preparations 
Serum albumin stock solutions were prepared by dissolving ~22 mg of lyophilized 
powder in 10 ml of 60 mM sodium phosphate buffer, pH 7.4. The samples were then 
filtered through PVDF filters. The protein concentrations of different stock solutions were 
determined spectrophotometrically, using molar absorption coefficients at  280 nm, i.e. 
36 500 M–1cm–1 for HSA (Painter et al., 1998), 43 827 M–1cm–1 for BSA, 43 385 M–1cm–
1 for both PSA and RbSA and 42 925 M–1cm–1 for SSA (Khan et al., 2013). The stock 
solutions were stored at 4 °C and were used within one week. 
An appropriate amount of individual site marker ligands (WFN, IDM and IBN) as well 
as herbicide (PM) was dissolved in 10 ml of ethanol to prepare their stock solutions. 
Working solutions of these site marker ligands/herbicide were obtained by diluting the 
stock solution with 60 mM sodium phosphate buffer, pH 7.4 to the desired concentrations. 
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3.2.3  Absorption spectroscopy 
Absorption measurements were made on a Perkin Elmer Lambda 25 UV/Vis 
spectrophotometer, using a pair of 1 cm path-length quartz cuvette. Scattering corrections, 
if required, were made by extrapolation of the absorbance values in  the wavelength range, 
360–340 nm to the desired wavelength (Tayyab and Qasim, 1986). 
3.2.4  Fluorescence spectroscopy 
Fluorescence measurements were carried out on a Jasco FP-6500 spectrofluorometer, 
equipped with a jacketed cell holder, connected to an external thermostated circulating 
water bath, using a 1 cm path-length quartz cuvette. Both excitation and emission slit 
widths were set at 10 nm while the scanning speed was fixed at 500 nm/min. The data 
pitch and the detector voltage used were 1 nm and 240 V, respectively. The fluorescence 
spectra were recorded in the wavelength range of  310–400 nm upon  exciting the  protein  
solution  at  295 nm.  
For three-dimensional (3-D) fluorescence measurements, emission scans were 
recorded in the wavelength range of 220–500 nm with a data pitch of 1 nm, while the 
excitation wavelength range was set at 220–350 nm with 5 nm intervals. The other 
scanning parameters were kept the same as mentioned above. The protein samples were 
prepared  by incubating  3 µM HSA both in the absence and the presence of PM (3 µM 
and 6 µM) for 1 h at 25 °C. 
3.2.5 Circular dichroism spectroscopy 
Circular dichroism (CD) spectra were recorded on a Jasco J-815 spectropolarimeter, 
attached with a Jasco PTC-423S/15 Peltier-type thermostated cell holder, under constant 
nitrogen flow at 25 °C. Far-UV (200–250 nm) CD spectral measurements were performed 
using a protein concentration of 3 µM in a 1 mm path-length quartz cuvette, whereas the 
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protein concentration and path-length of the cuvette used for near-UV (250–300 nm) CD 
spectral measurements were 10 µM and 10 mm, respectively. CD spectra were recorded 
both in the absence and the presence of PM using PM/HSA molar ratio of 2:1 and 1:1. 
3.2.6 Interaction study of PM with HSA 
The interaction between PM and HSA was investigated using fluorescence quenching 
titration method (Feroz et al., 2012). 
3.2.6.1 Fluorescence quenching titration 
The titration was performed at four different temperatures viz. 15, 25, 35 and 45 °C. A 
constant volume (300 µL) of the stock protein solution (30 µM), taken in different tubes, 
was titrated with increasing PM concentrations (0–7.2 µM) in 0.9 µM intervals. The total 
volume in each tube was made to 3.0 ml with 60 mM sodium phosphate buffer, pH 7.4. 
The mixture was incubated at constant temperature for 1 h before fluorescence 
measurements in the wavelength range, 310–400 nm upon excitation at 295 nm. 
3.2.6.2 Data analysis 
Inner filter effect correction 
The observed fluorescence intensity values were corrected for the inner filter effect, 
using the following equation (Lakowicz, 2006): 
Fcor = Fobs  e (Aex + Aem)/2              (1) 
where Fcor is the corrected fluorescence intensity, Fobs is the observed fluorescence 
intensity,  Aex and Aem are the absorbance values at the excitation and the emission 
wavelengths, respectively. 
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Quenching and binding parameters 
The decrease in the fluorescence intensity of HSA at max was analyzed using Stern-
Volmer equation (Lakowicz, 2006). 
F0 / F = Ksv [Q] + 1 = kq 0 [Q]  1             (2) 
where F0 and F are the fluorescence intensity values of HSA before and after the addition 
of the quencher (PM), respectively, Ksv is the Stern-Volmer constant, [Q] is the quencher 
concentration, kq is the bimolecular quenching rate constant and 0 is the excited state 
lifetime of  the biomolecule (HSA)  in  the  absence  of  the quencher and  its  value was 
taken as  6.38  10–9 s (Abou-Zied & Al-Shihi, 2008). 
Values of the association constant, Ka for PM-HSA interaction were obtained after 
treating the fluorescence quenching data according to the following equation (Bi et al., 
2004): 
log (F0 – F) / F = n log Ka – n log [1 / ([LT] – (F0 – F)[PT] / F0)]         (3) 
where n is the Hill coefficient, [LT] is the total ligand (PM) concentration and [PT] refers 
to the total protein (HSA) concentration. Ka values at different temperatures were 
determined from the plot of log (F0 – F) / F versus log [1 / ([LT] – (F0 – F)[PT] / F0)]. 
Thermodynamic parameters 
Thermodynamic parameters such as the entropy change (∆S) and the enthalpy change 
(∆H) of the binding reaction were obtained from the plot of 1n Ka versus 1 / T, based on 
the van’t Hoff equation (Raffa, 2003). 
1n Ka = –∆H / RT + ∆S / R              (4) 
where  T   is   the  absolute  temperature   (273  +  °C)   and   R   is   the   gas   constant 
(8.3145 J mol–1 K–1).             
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The values of Gibbs free energy change (∆G) were calculated by substituting the 
values of ∆H and ∆S in the following equation: 
∆G = ∆H – T∆S               (5) 
3.2.7 Thermal stability study 
Thermal stability of HSA (3 µM) was evaluated both in the absence and the presence 
of PM (6 µM) using fluorescence spectroscopy within the temperature range, 25–100 °C 
in equal increments of 5 °C. The protein sample, taken in a 1 cm path-length quartz cell 
was capped and placed in a jacketed cell holder. The samples were allowed to equilibrate 
for 6 min at each temperature before recording the fluorescence intensity at 343 nm. The 
sample containing the PM-HSA mixture was incubated for 1 h at 25 °C prior to 
fluorescence measurements at different temperatures. The other parameters were the 
same as those used in fluorescence spectroscopy. 
3.2.8 Site marker displacement study 
The competitive experiments were carried out at 25 °C using WFN and IDM as site I 
markers, whereas IBN was selected as site II marker. Increasing concentrations (0–6.3 
µM with 0.9 µM intervals) of PM were added to either HSA (3 µM) or an equimolar (3 
µM) mixture of site marker and HSA, preincubated for 1 h at 25 °C and the final mixture 
(3 ml) was further incubated for 1 h at 25 °C before fluorescence measurements. The 
fluorescence spectra of WFN-HSA complex were recorded in the wavelength range, 360–
480 nm upon excitation at 335 nm, whereas an excitation wavelength of 295 nm was used 
to record the fluorescence spectra of IDM-HSA and IBN-HSA complexes in the range of 
310–400 nm. 
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3.2.9 Molecular modeling method 
The structure of PM was constructed and geometry optimized with MMFF94 force 
field (Halgren, 1996) using Avogadro Software (Hanwell et al., 2012) and exported as a 
mol2 file. Docking, visualization and rendering simulation were performed using 
AutoDock 4.2 (Goodsell et al., 1996) and AutoDockTools 1.5.6 (Sanner, 1999) at the 
Academic Grid Malaysia Infrastructure. The crystal structure of HSA (PDB code 1BM0, 
2.5 Å resolution) was downloaded from the Protein Data Bank (Berman et al., 2000). 
Water molecules were removed and the atomic coordinates of chain A of 1BM0 were 
stored in a separate file and used as input for AutoDockTools, where polar hydrogens, 
Kollman charges and solvation parameters were added. In the case of the ligand PM, 
nonpolar hydrogens were merged and rotatable bonds were defined. The two binding sites 
(subdomains IIA and IIIA) were defined with the help of two grids of 70 × 70 × 70 points 
each with a grid space of 0.375 Å, centered at coordinates x = 35.26, y = 32.41 and z = 
36.46 for subsite IIA (site I) and x = 14.42, y = 23.55 and z = 23.31 for subsite IIIA (site 
II), respectively. The Lamarckian genetic algorithm with local search was used as the 
search engine, with a total of 100 runs for each binding site. In each run, a population of 
150 individuals with 27 000 generations and 250 000 energy evaluations were employed. 
Operator weights for crossover, mutation and elitism were set at 0.8, 0.02 and 1, 
respectively. For the local search, default parameters were used. Cluster analysis was 
performed on docked results using a root-mean-square deviation (rmsd) tolerance of 2.0 
Å. The protein–ligand complex was visualized and analyzed using AutoDockTools. 
3.2.10  Interaction study of PM with different mammalian serum albumins 
3.2.10.1 Fluorescence quenching titration and binding parameters 
Binding of PM to different serum albumins was studied by titrating a fixed amount of 
serum albumin (3 µM) with increasing concentrations (0.9–4.5 µM with 0.9 µM intervals) 
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of PM. The total volume of the mixture in each tube was made to 3.0 ml with 60 mM 
sodium phosphate buffer, pH 7.4. The fluorescence spectra were recorded after 1 h 
incubation at room temperature, in the same way as described in the section 3.2.4. Data 
analysis was made for the determination of binding parameters, Ksv and Ka after inner 
filter effect correction following the procedures described in the section 3.2.6.2. The ∆G 
values of the binding reaction were obtained from the Ka values, using the following 
equation: 
∆G = −RT ln Ka      (6) 
3.2.10.2 Warfarin displacement study 
Equimolar concentrations (3 µM each) of WFN, Sudlow’s site I marker and albumin 
were incubated for 1 h at room temperature (25 °C). Increasing concentrations (0−4.5 µM 
with 0.9 µM intervals) of PM were then added to WFN-albumin mixture and the 
fluorescence spectra were recorded in the wavelength range, 360−480 nm after 1 h 
incubation at room temperature, using an excitation wavelength of 335 nm. 
3.2.11 Statistical analysis 
Each of the individual experiments were conducted independently for three times and 
the data are presented as the mean standard deviation. Curve fitting and processing of 
statistical data were performed using OriginPro 8.5 software (originLab Corp., 
Northampton, MA, USA). 
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CHAPTER 4 
RESULTS AND DISCUSSION 
4.1  PM-HSA interaction 
Fluorescence spectroscopy is a useful tool for investigating ligand-protein interaction 
in terms of binding affinity, binding forces and mode of binding. The fluorescence 
spectrum of HSA mainly originates from tryptophan (Trp) residue, when an excitation 
wavelength of 295 nm is used (Lakowicz, 2006). 
4.1.1 PM-induced quenching of HSA fluorescence 
The protein (HSA) produced a fluorescence spectrum in the wavelength range, 310–
400 nm with an emission maxima at 343 nm, when excited at 295 nm (Figure 4.1). It is 
important to note that free PM did not produce any fluorescence within this wavelength 
range (spectrum ‘a’ in Figure 4.1). Addition of increasing concentrations of PM to HSA 
led to a progressive decrease in the fluorescence intensity along with a blue shift of 3 nm 
in the emission maxima at the highest PM concentration (Figure 4.1). About 50 % 
decrease in the fluorescence intensity was observed at 7.2 µM PM concentration (inset of 
Figure 4.1). Such attenuation of the fluorescence signal (fluorescence quenching) can be 
ascribed to a number of molecular interactions, which include excited-state reactions, 
molecular rearrangements, energy transfer, ground-state complex formation and collision 
quenching (Lakowicz, 2006). The slight blue shift in the emission maxima implied that 
the polarity around the Trp residue was reduced (Steinhardt et al., 1971). This seems 
reasonable as the binding of PM with several hydrophobic groups to the Sudlow’s site I 
of HSA, where the single Trp-214 is located, might have increased the hydrophobicity of 
the microenvironment around Trp residue. As shown in the sections 4.1.7 and 4.1.8, 
Sudlow’s  site I  has been suggested  to be the preferred binding site of PM. Similar blue  
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Figure 4.1:  Fluorescence quenching spectra of HSA (3 µM) induced by increasing 
PM concentrations in 60 mM sodium phosphate buffer, pH 7.4 at 25 °C. 
PM concentrations (spectra 1–9) were 0–7.2 µM with 0.9 µM intervals, 
while the excitation wavelength was 295 nm. Spectrum ‘a’ depicts the 
fluorescence spectrum of 7.2 µM  PM. Arrow represents the blue shift in 
the emission maximum of HSA with increasing PM concentrations. The 
inset shows quenching of the fluorescence intensity of HSA at 343 nm 
(FI343 nm) with increasing PM concentrations. 
  
a 
1 
9
a 
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shift in the emission maxima along with fluorescence quenching have also been observed 
upon interaction of other ligands with HSA (Sinisi et al., 2015; Sulkowska et al., 2008; 
Tunç et al., 2014). 
4.1.2 Quenching mechanism 
Quenching mechanism can be classified as either dynamic or static quenching. 
Molecular collisions between the fluorophore and the quencher are responsible for 
dynamic quenching, whereas static quenching is resulted from the complex formation 
between the fluorophore and the quencher (Lakowicz, 2006). These quenching 
mechanisms can be discriminated from each other based on their dependence on 
temperature. An increase in the bimolecular quenching rate constant is anticipated with 
increasing temperature due to increase in the rate of diffusion at higher temperature. On 
the other hand, value of the static quenching constant remains inversely proportional to 
temperature due to destabilization of the complex at higher temperature (Lakowicz, 2006). 
In order to ascertain the quenching mechanism involved in PM-HSA system, fluorescence 
quenching titration experiments were carried out at four different temperatures, i.e. 15, 
25, 35 and 45 °C. Analysis of the fluorescence quenching data according to Eq. 2 yielded 
the linear Stern-Volmer plots with correlation coefficient, r  0.996 (Figure 4.2). The 
values of the Stern-Volmer constant, Ksv, as obtained from the slope of these plots are 
listed in Table 4.1. Ksv values correlated very well with temperature, T (r = 0.9998), 
showing a linear decrease in Ksv with increasing temperature (Figure 4.3) and obeyed the 
following straight line equation: 
Ksv = –2793.7 T + 220818              (6) 
In view of the decrease in the Ksv value with temperature, PM-induced quenching of HSA 
fluorescence can be characterized as static quenching, which affirmed the formation of 
the complex between PM and HSA. Furthermore, the value of the quenching constant, kq  
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Figure 4.2: Stern-Volmer plots for the fluorescence quenching data of PM-HSA 
system at four different temperatures.  
  
15 °C (r = 0.997) 
25 °C (r = 0.999) 
35 °C (r = 0.996) 
45 °C (r = 0.996) 
\ 
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Table 4.1: Binding parameters for PM-HSA interaction at different temperatures. 
 
 
  
T 
 (°C) 
Ksv  
(M–1) 
kq  
(M–1 s–1) 
Ka 
 (M
–1) 
    
15 (1.80  0.04) × 105 (3.68  0.04) × 1013 (2.35  0.06) × 105 
25 (1.50  0.01) × 105 (3.28  0.01) × 1013 (2.09  0.06) × 105 
35 (1.23  0.08) × 105 (2.18  0.08) × 1013 (1.39  0.05) × 105 
45 (0.95  0.10) × 105 (1.57  0.10) × 1013 (1.00  0.08) × 105 
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Figure 4.3: Plot showing the relationship between the Stern-Volmer constant (Ksv) 
and temperature (T). 
  
× 
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calculated at different temperatures using Eq. 2 was found to fall in the order of magnitude 
of 1013 M–1 s–1 (Table 4.1). These values of kq were much higher than the typical diffusion-
controlled rate constant of the biomolecule (2 × 1010 M–1 s–1), which further explained 
that the quenching was initiated by the formation of the complex between PM and HSA 
rather than through dynamic collisions (Lakowicz, 2006; Lakowicz and Weber, 1973).  
4.1.3  Association constant, thermodynamic parameters and binding forces 
The association constant (Ka) of PM-HSA interaction was determined at different 
temperatures using the double logarithmic plots, as shown in Figure 4.4. The Ka values 
had fallen in the order of magnitude of 105 M–1 (Table 4.1), which was suggestive of 
moderately strong binding affinity between PM and HSA (Qin et al., 2010; Zheng et al., 
2016). Such binding affinity is physiologically significant in two ways. First, it allows the 
level of free PM in blood circulation under control, which may be toxic to other tissues. 
Secondly, such intermediate affinity would enable easy dissociation of PM at the target 
site for detoxification and clearance (Peters, 1995). The results show that the Ka value 
decreased with increasing temperature and was coincided with the static quenching 
mechanism (Lakowicz, 2006). The decrease in the Ka value with increasing temperature 
clearly suggested weakening of the PM-HSA complex at higher temperature (Feroz et al., 
2012; Petitpas et al., 2001). 
Treatment of the binding data according to van’t Hoff plot (Figure 4.5), using Eq. 4 
yielded the values of  ∆H and ∆S of the binding reaction  as  22.41 kJ mol–1  and  25.67  
J mol–1 K–1, respectively (Table 4.2). These values were used in Eq. 5 to compute the 
value of ∆G (Table 4.2). Negative sign of the ∆G values revealed the spontaneous nature 
of the binding process. Thermodynamic parameters, i.e. ∆H and ∆S are useful in 
investigating the nature of forces involved in ligand-protein interaction (Raffa, 2003). 
Generally, four  types of  non-covalent forces  viz. hydrogen bonds, electrostatic, van der  
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Figure 4.4: Plots of log (F0 – F) / F versus log [1 / ([LT] – (F0 – F)[PT] / F0)] for the 
fluorescence quenching data of PM-HSA system at four different 
temperatures.  
  
    
15 °C (r = 0.998) 
25 °C (r = 0.998) 
35 °C (r = 0.996) 
45 °C (r = 0.998) 
\ 
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Figure 4.5: van’t Hoff plot for PM-HSA interaction. Values of the association 
constant, Ka were obtained from the double logarithmic plot, shown in 
Figure 4.4. 
  
× × 
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Table 4.2: Thermodynamic parameters for PM-HSA interaction. 
 
  
T  
(°C) 
∆S  
(J mol–1  K–1) 
∆H  
(kJ mol–1) 
∆G  
(kJ mol–1) 
  
 
 
25.67 
 
 
 
–22.41 
 
15 – 29.80 
25 – 30.06 
35 – 30.31 
45 – 30.57 
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Waals and hydrophobic interactions are believed to stabilize ligand-protein complexes 
(Olsson et al., 2008). According to Ross and Subramanian (1981), a positive sign for ∆S 
suggests the involvement of both hydrophobic and electrostatic interactions in the binding 
reaction. Since PM contains a benzene ring along with several other hydrophobic groups, 
which are liable to interact with the protein’s hydrophobic residues, involvement of 
hydrophobic interactions between PM and HSA seems plausible. Dissolution of highly 
ordered domains of water around protein and ligand molecules might have increased the 
entropy upon ligand-protein complex formation. On the other hand, a significantly large 
negative value of ∆H ruled out the participation of electrostatic forces in PM-HSA 
complexation, as electrostatic forces are usually accompanied by a very small ∆H value 
(Ross and Subramanian, 1981). Absence of any ionizable group in PM further supports 
the exclusion of electrostatic forces in PM-HSA complexation. However, a single force 
cannot be presumed to be the sole force for the stabilization of the ligand-protein complex. 
Since hydrogen bond formation in low dielectric media has been found to be an 
exothermic process, which is always associated with a negative ∆H value (Ross and 
Subramanian, 1981), it is conceivable to think about the involvement of hydrogen 
bonding as an additional force in PM-HSA complex formation, based on the negative ∆H 
value of the interaction. This was well supported by our molecular docking results 
(section 4.1.8), showing hydrogen bonding pattern between PM and HSA. 
4.1.4  PM-induced structural changes in HSA 
The effect of PM-HSA interaction on the secondary and tertiary structures of HSA was 
studied using far-UV and near-UV CD spectroscopy.  
Appearance of two minima at 208 and 222 nm in the far-UV CD spectrum of HSA 
(Figure 4.6) characterized the presence of α-helical structure (Taboada et al., 2006). A 
significant alteration in these signals in  the presence  of  PM at 2:1 PM/HSA molar ratio  
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Figure 4.6:  Far-UV CD spectra of HSA (3 µM) in the absence and the presence of 6 
µM PM. The spectra were obtained in 60 mM sodium phosphate buffer, 
pH 7.4 at 25 °C.   
 HSA 
 PM-HSA 
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clearly suggested secondary structural changes in HSA due to PM binding. Secondary 
structural changes in HSA upon ligand binding have been reported earlier with other 
ligands (Chakraborty et al., 2015; Zhang et al., 2012).  
Near-UV CD spectrum of HSA was characterized by the presence of minima at 263 
and 269 nm and shoulders at 273 and 291 nm (Figure 4.7) due to disulfide and aromatic 
chromophores of HSA (Rogers and Hirst, 2004). Any change in the near-UV CD 
spectrum reflects the change in the tertiary structure of the protein. Interestingly, addition 
of PM to HSA in 1:1 molar ratio significantly affected the near-UV CD spectrum (Figure 
4.7), which indicated PM-induced tertiary structural change as a result of PM binding to 
HSA. Several earlier reports have shown ligand-induced tertiary structural changes 
(Chakraborty et al., 2015; Juárez et al., 2009). 
4.1.5  PM-induced microenvironmental perturbations around protein fluorophores 
Microenvironmental perturbations around aromatic fluorophores (Trp and Tyr) of 
HSA, induced by PM binding were investigated by comparing the 3-D fluorescence 
spectra of HSA in the absence and presence of PM. The 3-D fluorescence spectrum and 
corresponding contour map of HSA (Figure 4.8) showed the presence of peaks ‘1’ and ‘2’ 
due to Trp and Tyr residues. In addition, two minor peaks, viz. peaks ‘a’ and ‘b’, 
characterized as the Rayleigh scattering peak (em = ex) and the second-order scattering 
peak (em = 2ex), respectively, were also visible in the 3-D fluorescence spectrum 
(Ishtikhar et al., 2014). Qualitatively similar 3-D fluorescence spectra were observed in 
the presence of PM (Figures 4.9 and 4.10). However, both reduction in the fluorescence 
intensity and blue shift in the emission maxima were noticed in the presence of PM, being 
more pronounced at higher PM/HSA (2:1) molar ratio (Figure 4.10). Peak ‘1’ (ex = 280 
nm) experienced 14 % and 30 % decrease in the fluorescence intensity at PM/HSA molar 
ratios of 1:1 and 2:1, respectively, whereas reduction in the fluorescence intensity of peak  
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Figure 4.7:  Near-UV CD spectra of HSA (10 µM) in the absence and the presence 
of 10 µM PM. The spectra were obtained in 60 mM sodium phosphate 
buffer, pH 7.4 at 25 °C.  
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Figure 4.8: Three-dimensional fluorescence spectrum (top) and corresponding 
contour map (bottom) of 3 µM HSA, as obtained in 60 mM sodium 
phosphate buffer, pH 7.4 at 25 °C. 
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Figure 4.9: Three-dimensional fluorescence spectrum (top) and corresponding 
contour map (bottom) of 1:1 PM-HSA system. The spectrum was 
obtained in 60 mM sodium phosphate buffer, pH 7.4 at 25 °C, using a 
protein concentration of 3 µM. 
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Figure 4.10: Three-dimensional fluorescence spectrum (top) and corresponding 
contour map (bottom) of 2:1 PM-HSA system. The spectrum was obtained 
in 60 mM sodium phosphate buffer, pH 7.4 at 25 °C, using a protein 
concentration of 3 µM.  
b 
2 
1 
a 
1 
b 
2 
a 
55 
 
‘2’  (ex = 235 nm) was found to be 20 % and 32 %, respectively, at the same molar ratios 
(Table 4.3). Such decrease in the fluorescence intensity experienced in both peaks ‘1’ and 
‘2’ was also associated with 2 and 5 nm blue shift in peak ‘1’ and 5 and 15 nm blue shift 
in peak ‘2’ at PM/HSA molar ratios of 1:1 and 2:1, respectively. Blue shift in the emission 
maxima clearly suggested the changes in the microenvironment from polar to non-polar 
in the presence of PM. These changes in the fluorescence characteristics suggested that 
binding of PM to HSA produced significant microenvironmental perturbations around 
Trp and Tyr residues of HSA.  
4.1.6 PM-induced thermal stabilization of HSA 
In order to study the effect of PM binding on the thermal stability of HSA, fluorescence 
intensity of HSA at 343 nm was monitored at different temperatures (25–100 °C) in the 
absence and the presence of PM (PM/HSA molar ratio of 2:1). A progressive decrease in 
the fluorescence intensity was observed up to 70 °C, followed by a slow decrease beyond 
it (Figure 4.11). This result was similar to the thermal stability profile of HSA reported 
earlier (Flora et al., 1998; Picó, 1997). Presence of PM in the incubation mixture showed 
significant protection of HSA from thermal-induced destabilization throughout the 
temperature range studied (Figure 4.11). Quantitatively, around 55 % decrease in the 
fluorescence intensity at 343 nm was observed at 100 °C in the presence of PM against 
75 % quenching noted in its absence. These results clearly suggested increased thermal 
stability of HSA in the presence of PM due to stabilization of the complex by non-
covalent forces, which required higher temperature to be broken down (Yeggoni et al., 
2015). This provided another evidence in support of the formation of PM-HSA complex.  
4.1.7  Identification of the PM binding site on HSA 
The two principal ligand binding sites of HSA, namely Sudlow’s sites I and II are 
located  in  the hydrophobic cavities in subdomains  IIA and IIIA, respectively (Carter et  
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Table 4.3: Three-dimensional fluorescence spectral characteristics of HSA and 
PM-HSA system. 
 
 
  
System Peak no. Peak position 
[ex/λem, nm/nm] 
Intensity 
    
 a 220/220  350/350  18.8  73.2 
HSA 
b 250/500  85.6 
1 280/338 343.9 
 2 235/333 160.4 
    
 a 220/220  350/350  19.5  80.1 
[PM]:[HSA]= 1 : 1 
b 250/500  83.9 
1 280/336 295.7 
 2 235/328 128.9 
    
 a 220/220  350/350  19.4  80.2 
[PM]:[HSA]= 2 : 1 
b 250/500  79.1 
1 280/333 239.8 
 2 235/318 109.0 
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Figure 4.11: Thermal stability profiles of HSA and 2:1 PM-HSA system, as studied 
by fluorescence measurements at 343 nm in the temperature range, 25–
100 °C. The fluorescence measurements were made in 60 mM sodium 
phosphate buffer, pH 7.4, using a protein concentration of 3 µM and 
excitation wavelength of 295 nm. 
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al., 1989; Sudlow et al., 1975). Heterocyclic compounds such as warfarin, indomethacin 
and phenybutazone tend to bind at site I, whereas smaller aromatic compounds viz. 
ibuprofen, ketoprofen and diazepam generally have high affinity for site II (Curry, 2002). 
These compounds are widely used as the site markers due to their high affinities towards 
these binding sites. In order to identify the binding site of PM on HSA, competitive 
experiments were carried out using WFN and IDM as the site I markers and IBN as the 
site II marker. 
The displacing action of PM on WFN-HSA (1:1) complex was studied by monitoring 
the change in the fluorescence spectrum of the WFN-HSA complex, which was 
characterized by the presence of an emission maxima at 383 nm upon excitation at 335 
nm (spectrum ‘1’ in Figure 4.12). This method seems reliable since the free forms of HSA 
and PM as well as the PM-HSA complex did not produce significant fluorescence spectra 
within the wavelength range, 360–480 nm (spectra ‘b’–‘d’ in Figure 4.12). Even free 
WFN (spectrum ‘a’) produced relatively weaker signal at 383 nm compared to WFN-
HSA complex. Addition of increasing PM concentrations to the WFN-HSA complex 
produced a decreasing trend in the fluorescence spectra (spectra ‘2’–‘8’ in Figure 4.12). 
Nearly 40 % decrease in the fluorescence intensity was observed at the highest PM 
concentration (6.3 µM) used (inset of Figure 4.12), which clearly reflected the WFN 
displacing action of PM from its binding site on HSA, i.e. site I.  
In order to ascertain the location of the PM binding site, fluorescence quenching 
spectra of PM-HSA complex were recorded both in the absence and the presence of other 
site markers, IDM (for site I) and IBN (for site II), using an excitation wavelength of 295 
nm (Figure 4.13). To compare the effect of IDM and IBN on PM-HSA system, the 
fluorescence quenching data were analyzed using Eq. 3 and the corresponding Ka values 
were determined from the double logarithmic plots (Figure 4.14). The Ka value of the 
PM-HSA  system (2.09  105 M–1)  was significantly reduced  to nearly  half (1.11  105   
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Figure 4.12: Quenching of the fluorescence spectrum of 1:1 WFN–HSA complex 
(spectrum 1) induced by increasing PM concentrations (ex = 335 nm). 
The PM concentrations used were 0.9–6.3 µM with 0.9 µM intervals 
(spectra 2–8). The fluorescence spectra, obtained with 3 µM WFN 
(spectrum ‘a’), 3 µM HSA (spectrum ‘b’), 6 µM PM (spectrum ‘c’) and 
2:1 PM–HSA complex (spectrum ‘d’) are also shown. The inset shows 
quenching of the fluorescence intensity of WFN-HSA complex at 383 
nm (FI383 nm) with increasing PM concentrations. 
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Figure 4.13: Fluorescence quenching spectra of HSA (A), 1:1 IBN-HSA complex (B) 
and 1:1 IDM-HSA complex (C) in the absence (spectrum 1) and the 
presence (spectra 2–8) of increasing PM concentrations  (0.9–6.3 µM 
with 0.9 µM intervals), obtained in   60 mM sodium phosphate buffer, 
pH 7.4 at 25 °C. 
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Figure 4.14: Double logarithmic plots for the fluorescence quenching data, obtained 
with HSA (3 µM), 1:1 IBN-HSA complex and 1:1 IDM-HSA complex 
with increasing PM concentrations, as shown in Figure 4.13 A, B and C, 
respectively. 
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M–1) in the presence of IDM, but showed no significant variation (1.92  105 M–1) in the 
presence of IBN (Table 4.4). From these results, it can be deduced that the binding affinity 
of PM towards HSA was significantly affected by the presence of IDM, whereas no 
significant change in the binding affinity was noticed in the presence of IBN. Therefore, 
site I seems to be the preferred binding site of PM, which was further supported by the 
molecular modeling results. 
4.1.8 Molecular modeling 
A molecular modeling study was conducted to predict the binding site of PM on HSA 
and to confirm the results of the displacement experiments described above. A total of 17 
multimember conformational clusters were obtained for site I from 100 docking runs. The 
highest populated cluster had 42 out of 100 conformations with the lowest mean binding 
energy as −33.4 kJ mol–1 (Figure 4.15A). For the binding site II, 10 multimember 
conformational clusters, possessing lowest mean binding energy of −23.6 kJ mol–1 were 
identified, with the highest populated cluster having 42 members out of 100 
conformations (Figure 4.15B). As the docking energy of the most favorable docking 
conformation in site II was larger than the one in site I, it revealed that PM showed a 
binding preference for the drug binding site I (subdomain IIA) of HSA. 
The results of these docking studies were in good agreement with the displacement 
experiments discussed above. The predicted binding model with the lowest docking 
energy (−33.4 kJ mol–1) was then used for binding orientation analysis (Figure 4.16). The 
binding site (defined by the amino acid residues within 5 Å distance from the ligand) was 
found to be deep inside the protein structure and mostly located in a hydrophobic cleft, 
lined by the following  amino  acid  residues:  Tyr-150,  Glu-153,  Lys-195, Gln-196,  
Lys-199, Trp-214, Arg-218, Leu-219, Arg-222, Phe-223, Leu-238, Val-241, His-242, 
Arg-257,  Ser-287,  Ile-290,  Ala-291 and Glu-292. Presence of hydrophobic amino acid  
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Table 4.4: Association constants for the site marker displacement study of PM-
HSA interaction. 
Site marker Ka  
(× 105 M–1) 
r 
- 2.09  0.06 0.995 
IBN 1.92  0.07 0.995 
IDM 1.11  0.06 0.998 
r is the correlation coefficient.  
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Figure 4.15: Cluster analyses of the AutoDock docking runs of PM in the drug 
binding site I (A) and site II (B) of HSA (1BM0). 
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Figure 4.16: Predicted orientation of the lowest docking energy conformation of PM 
(rendered in ball and stick) in the binding site I (subdomain IIA) of HSA. 
The different domains, namely, domain I, II and III of HSA are shown in 
red, blue and green, respectively. The zoomed-in view of the binding site 
shows the hydrogen bonds (green lines) formed between the amino acid 
residues of HSA (rendered in yellow ball and stick) and PM in the 
binding site I. 
  
66 
 
residues at the binding site of HSA might have contributed towards the stability of the 
ligand-HSA complex through hydrophobic interactions. However, the presence of several 
polar amino acid residues within the proximity of the bound ligand indicated that the 
interaction between the ligand and HSA at this site cannot be presumed to be exclusively 
hydrophobic in nature. Furthermore, five hydrogen bonds were predicted in the PM-HSA 
complex docking conformation at site I, against three hydrogen bonds at site II (Table 
4.5). These results further supported the involvement of both hydrogen bonds and 
hydrophobic interactions in PM-HSA complex formation. 
4.2 Interaction of PM with different mammalian serum albumins 
4.2.1 PM-induced quenching of albumin fluorescence  
The fluorescence quenching results of different serum albumins, i.e. BSA, SSA, PSA, 
HSA and RbSA, obtained in the presence of increasing PM concentrations are shown in 
Figure 4.17A–E. Quantitative differences in the values of the fluorescence intensity, 
obtained with these albumins can be ascribed to the number of Trp residues in these 
proteins, that contribute towards the fluorescence intensity upon excitation at 295 nm 
(Lakowicz, 2006). BSA, SSA and PSA with two Trp residues produced higher 
fluorescence intensity (Figure 4.17A–C, Table 4.6) compared to HSA and RbSA (Figure 
4.17D–E, Table 4.6), which possess single Trp residue (Pajot, 1976). On the other hand, 
the emission maxima of these albumins were found to fall in the range, 341–345 nm, 
characteristic of Trp residue(s) (Table 4.6) (Vivian and Callis, 2001).  
As evident from Figure 4.17A–E, addition of PM to these albumins produced 
quenching in the fluorescence intensity in a concentration dependent manner. Such 
quenching was suggestive of the binding of PM to these albumins, as similar quenching 
was observed with the binding of many ligands to serum albumins  (Han et al., 2009; 
Feroz et al., 2015; Kamtekar et al., 2013; Samari et al., 2012). Values of the fluorescence  
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Table 4.5: Predicted hydrogen bonds between interacting atoms of the amino acid 
residues of HSA (1BM0) and PM at site I and site II. 
HSA binding site Protein atom Ligand atom Distance (Å) 
 
Site I 
 TYR  ̵150: HH O (nitro, C6) 1.98 
 LYS ̵ 199: HZ1 O (nitro, C2) 2.19 
ARG ̵ 222: HH21 O (nitro, C2) 1.97 
ARG ̵ 257: HE O (nitro, C6) 2.15 
ARG ̵ 257: HH22 O (nitro, C6) 1.95 
    
 
Site II 
LYS ̵ 413: HZ3 
LYS ̵ 414: HZ1 
LYS ̵ 414: HZ2 
O (nitro, C2) 
O (nitro, C6) 
O (nitro, C6) 
2.20 
1.55 
2.05 
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Figure 4.17:    Fluorescence quenching spectra of different serum albumins (3 µM ) 
induced by increasing PM concentrations in 60 mM sodium phosphate 
buffer, pH 7.4 at 25 °C. PM concentrations (spectra 1–6) were 0–4.5 µM 
with 0.9 µM intervals, while the excitation wavelength was 295 nm. (A) 
BSA, (B) SSA, (C) PSA, (D) HSA and (E) RbSA. 
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intensity at the emission maxima, obtained at different PM concentrations were 
transformed into the relative fluorescence intensity by taking the fluorescence intensity 
of these albumins in the absence of PM as 100. Figure 4.18 shows change in the relative 
fluorescence intensity at the emission maxima with increasing PM concentrations, 
obtained with different serum albumins. All these albumins showed gradual decrease in 
the fluorescence intensity with increasing PM concentrations. However, a comparison of 
the quenching pattern, obtained with these albumins suggests lesser extent of the 
fluorescence quenching with PSA and RbSA compared to that observed with SSA, HSA 
and BSA at the highest PM/albumin molar ratio (1.5:1). Quantitatively, about 51 %, 39 % 
and 36 % quenching was observed with SSA, HSA and  BSA, respectively, compared to 
PSA and RbSA, showing 19 % and 26 % quenching, respectively (Figure 4.18, Table 4.6). 
4.2.2 Binding parameters for PM-albumin interaction 
In order to find out the source of PM-induced quenching, fluorescence quenching data 
were treated according to Eq. 2 and the KSV values were obtained from the slope of the 
linear Stern-Volmer plots (Figure 4.19). In line to the quenching pattern (Table 4.6), BSA, 
SSA and HSA showed higher KSV values compared to those obtained with PSA and RbSA 
(Table 4.7). Substitution of KSV values in Eq. 2 yielded the values of bimolecular 
quenching constant, kq. These kq values had fallen in the order of 10
13 M–1 s–1 for BSA, 
SSA and HSA and 1012 M–1 s–1 for PSA and RbSA. Values of kq higher than 10
10 M–1 s–1 
(diffusion-controlled limit) simply reflects complex formation (Lakowicz, 2006). Thus, 
it appears that PM-induced fluorescence quenching might have been resulted from static 
quenching mechanism, which supports the complex formation.  
Binding affinity of PM towards different serum albumins was determined by analyzing 
the fluorescence quenching data according to Eq. 3. The values of the association constant, 
Ka for different PM-albumin systems were obtained from the resulting double logarithmic  
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Figure 4.18: Plot showing a comparison of the fluorescence quenching of different 
serum albumins at their emission maxima with increasing PM 
concentrations.  
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Table 4.6: Fluorescence characteristics of different serum albumins in the absence 
and the presence of PM. 
Albumin Emission maxima   
(nm) 
Intensity 
(a.u.) 
% Quenching 
([PM]/[Albumin]=1.5:1) 
BSA 345 424 36.3  2.6 
SSA 341 378 50.9  2.3 
PSA 343 384 19.4  1.6 
HSA 343 193 38.7  1.5 
RbSA 343 125 26.0  1.6 
 
  
72 
 
 
 
 
 
 
 
Figure 4.19: Stern-Volmer plots for the fluorescence quenching of different serum 
albumins by PM. The symbols used for various serum albumins are the 
same as used in Figure 4.18.   
r = 0.996 
r = 0.999 
r = 0.999 
r = 0.990 
r = 0.999 
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Table 4.7: Binding parameters and free energy change for the interaction between 
PM and different serum albumins. 
Albumin KSV  
(M–1) 
Ka  
(M–1) 
∆G  
(kJ mol–1) 
BSA (1.29  0.14)  105 (1.71  0.15)  105 –29.86 
SSA (2.44  0.04)  105 (3.27  0.24)  105 –31.46 
PSA (5.57  0.30)  104 (8.88  0.08)  104 –28.23 
HSA (1.51  0.01)  105 (2.18  0.12)  105 –30.46 
RbSA (8.10  0.14)  104 (9.74  0.31)  104 –28.46 
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plots (Figure 4.20) and are given in Table 4.7. Based on the PM binding affinity, these 
albumins can be arranged in the order: SSA > HSA > BSA > RbSA > PSA. Although the 
sequence and protein characteristics of these albumins show high degree of similarity 
(Michaud et al., 2009), binding affinity of ligands varies considerably among the species 
according to the degree of phylogenetic relationship (Day and Myszka, 2003). Such 
species differences in ligand-albumin interaction have been reported earlier (Kosa et al., 
1997; Feroz et al., 2015; Tayyab et al., 2003). The Gibbs free energy change (∆G) of the 
binding reaction was calculated using Eq. 6 (Table 4.7) and the negative values of ∆G for 
all PM-albumin systems suggested that the binding reactions were feasible (Ross and 
Subramanian, 1981).  
4.2.3 Warfarin displacement results 
As PM was found to bind to site I of HSA, based on site marker displacement and 
molecular modeling results described above (sections 4.1.7 and 4.1.8), a comparison for 
the WFN displacing action of PM on the complexes of WFN with other albumins was 
made. Spectrum 1 in Figure 4.21 shows the fluorescence spectrum of WFN-SSA complex, 
when excited at 335 nm. The spectrum was characterized by the presence of an emission 
maxima at 383 nm. Addition of increasing concentrations of PM displaced WFN from its 
binding site, as reflected from the progressive decrease in the fluorescence intensity 
(spectra 2-6 in Figure 4.21). In this range of wavelength, the fluorescence signals 
produced by SSA, PM and PM-HSA mixture (spectra ‘b’–‘d’ in Figure 4.21) were 
insignificant. Even free WFN (spectrum ‘a’ in Figure 4.21) produced relatively weaker 
signal at 383 nm compared to WFN-SSA complex. WFN displacement results, obtained 
with other serum albumins, i.e. BSA (Figure 4.22), PSA (Figure 4.23), RbSA (Figure 
4.24) and HSA (Figure 4.12) were qualitatively similar to those obtained with SSA, but 
showed significant differences in the extent of fluorescence quenching. This can be 
clearly  seen  from  the decrease in the relative fluorescence intensity of different WFN- 
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Figure 4.20: Double logarithmic plots for the fluorescence quenching of different 
serum albumins by PM. The symbols used for various serum albumins 
are the same as used in Figure 4.18.  
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Figure 4.21: Fluorescence spectra of 1:1 WFN-SSA complex (spectrum 1) in the 
presence of increasing PM concentrations (ex = 335 nm). The PM 
concentrations were 0.9–4.5 µM with 0.9 µM intervals (spectra 2–6). The 
spectra labelled as ‘a’, ‘b’, ‘c’ and ‘d’ refer to the fluorescence spectra of 
WFN (3 µM), SSA (3 µM), PM (4.5 µM) and PM-SSA (1.5:1) complex, 
respectively. 
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Figure 4.22: Fluorescence spectra of 1:1 WFN-BSA complex (spectrum 1) in the 
presence of increasing PM concentrations (ex = 335 nm). The PM 
concentrations were 0.9–4.5 µM with 0.9 µM intervals (spectra 2–6). The 
spectra labelled as ‘a’, ‘b’, ‘c’ and ‘d’ refer to the fluorescence spectra of 
WFN (3 µM), BSA (3 µM), PM (4.5 µM) and PM-BSA (1.5:1) complex, 
respectively. 
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Figure 4.23: Fluorescence spectra of 1:1 WFN-PSA complex (spectrum 1) in the 
presence of increasing PM concentrations (ex = 335 nm). The PM 
concentrations were 0.9–4.5 µM with 0.9 µM intervals (spectra 2–6). The 
spectra labelled as ‘a’, ‘b’, ‘c’ and ‘d’ refer to the fluorescence spectra of 
WFN (3 µM), PSA (3 µM), PM (4.5 µM) and PM-PSA (1.5:1) complex, 
respectively. 
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Figure 4.24: Fluorescence spectra of 1:1 WFN-RbSA complex (spectrum 1) in the 
presence of increasing PM concentrations (ex = 335 nm). The PM 
concentrations used were 0.9–4.5 µM with 0.9 µM intervals (spectra 2–
6). The spectra labelled as ‘a’, ‘b’, ‘c’ and ‘d’ refer to the fluorescence 
spectra of WFN (3 µM), RbSA (3 µM), PM (4.5 µM) and PM-RbSA 
(1.5:1) complex, respectively. 
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albumin (1:1) complexes at 383 nm with increasing PM concentrations, as shown in 
Figure 4.25. Values of the percentage fluorescence quenching of different WFN-albumin 
complexes induced by the highest PM concentration (4.5 µM) are listed in Table 4.8. 
Complexes of WFN with BSA and RbSA showed close similarity to HSA in terms of 
percentage quenching, as 27 % and 31 % quenching were observed with BSA and RbSA, 
respectively, against 34 % quenching observed with HSA. On the other hand, SSA 
showed relatively higher degree (48 %) of quenching, whereas a lesser degree (23 %) of 
quenching was displayed by PSA.  
A comparison of the PM binding properties of various serum albumins as well as WFN 
displacement results showed close similarity between BSA and HSA.  
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Figure 4.25: Plots showing quenching of the fluorescence intensity at 383 nm of 
different 1:1 WFN-albumin complexes with increasing PM 
concentrations. The symbols used for various serum albumins are the 
same as used in Figure 4.18. 
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Table 4.8:  Fluorescence quenching of different WFN-albumin (1:1) complexes in 
the presence of 4.5 µM PM. 
Albumin % Quenching 
BSA 27.4  0.2 
SSA 47.8  1.4 
PSA 23.3  1.3 
HSA 34.0  0.5 
RbSA 31.0  1.1 
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CHAPTER 5 
CONCLUSION 
Spectroscopic results showed moderately strong binding affinity between PM and 
HSA. Both hydrophobic interactions and hydrogen bonds were involved in stabilizing the 
PM-HSA complex. While changes in the secondary and tertiary structures of HSA were 
noticed upon complexation, protein’s thermal stability was increased. Sudlow’s site I, 
located in subdomain IIA was found to be the preferred binding site of PM on HSA. Based 
on the results obtained with other serum albumins, BSA was found to be closely similar 
to HSA, as evident from the PM-induced fluorescence quenching pattern, binding affinity 
as well as WFN displacement results. Thus, bovine can be considered as a suitable animal 
model for further exploration on toxicological effects of PM. These results may be useful 
in understanding the toxicity of PM in human subject. 
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ABSTRACT
Interaction of pendimethalin (PM) herbicide with the major transporter in human circulation,
human serum albumin (HSA), was studied using ﬂuorescence, circular dichroism (CD), and molec-
ular modeling methods. The attenuation of the ﬂuorescence intensity of HSA in the presence of
PM revealed formation of the PM–HSA complex. Analysis of the ﬂuorescence quenching data
showed moderately strong binding afﬁnity between PM and HSA. Both hydrophobic interactions
and hydrogen bonding were suggested to stabilize the PM–HSA complex, based on thermody-
namic data. Binding of PM toHSA induced perturbation in themicroenvironment around the aro-
matic ﬂuorophores as well as secondary and tertiary structural changes in the protein. Complexa-
tion of PMwith HSA led to an increase in its thermal stability. Both site marker displacement and
molecularmodeling results suggested site I, located in subdomain IIA as the preferred binding site
of PM onHSA.
K EYWORDS
ﬂuorescence quenching, herbicide, human serum albumin, ligand–protein interaction,
pendimethalin
1 INTRODUCTION
Herbicides have been found useful in improving crop production in
agricultural ﬁelds. However, their extensive use has provoked envi-
ronmental and toxicological threats due to their persistency in the
environment. [1] Pendimethalin (PM), a member of the dinitroaniline
group of herbicides is a soil residual pre-emergence herbicide, which
is used primarily for the control of most annual grasses and certain
broad-leaved weeds in various crops such as corn, wheat, soybeans,
and grapes. PM represses both root and shoot development via inhi-
bition of chromosome separation and cell wall formation during cell
mitosis. [2,3] PM is a widely used herbicide in the world, particularly in
the developed countries.
Owing to its vast usage, PM has been detected as a contaminant
in the water sources in the United States, [4] Denmark, [5] Spain, [6] and
France. [7] Theharmful chemicals of herbicides in the soilmay leach into
the water sources and cycle in the food web from aquatic organism
to human being. [1] Several studies have reported the adverse effects
of PM on the aquatic organisms including phytoplankton, zooplank-
ton, bottom fauna, [8] and rainbow trout. [9] Numerous in vitro studies
have shown induction of chromosomal aberration and micronuclei in
bone marrow cells of PM-treated mice, [10] DNA strand breaks in Chi-
nese hamster ovary cells upon exposure to PM [11] and deactivation
of ethoxyresoruﬁn-O-deethylase activity in the liver of PM-treated
ﬁsh. [12] Nevertheless, it is of much concern about the effects of PM on
humans as theharmful compounds in theherbicidesmay reachhumans
directly through air after aerosol application or indirectly via food and
drinking water.
Interaction of exogenous compounds with the plasma proteins in
human circulation decides the fate of their availability, metabolism,
and distribution in the body. Thus, interaction studies with the trans-
port proteins become important to decipher their action in the human
body. Most of the exogenous and endogenous compounds in our body
are being carried through human serum albumin (HSA), which is the
major transport and depot protein in the blood circulation. It is a single
polypeptide chain of 585 amino acid residues with a sole tryptophan
residue (Trp-214) and is composed of three homologous domains, I, II,
and III.Most of the compounds have been found to bindwith high afﬁn-
ity to Sudlow’s sites I and II, which are located in subdomains IIA and
IIIA, respectively. [13,14] The toxicity of a herbicide depends on the level
of its free concentration in the blood stream. Therefore, binding of a
herbicide to HSA is toxicologically important as it can reduce the con-
centrationof freeherbicide.However, interactionof other endogenous
substances or drugs with HSA at the same binding site of the herbicide
might strongly affect its distribution, elimination, as well as its toxic
properties. [15] Furthermore, unusually high afﬁnity of the herbicide to
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